|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00180232 |
|
Date of registration:
|
14/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness
|
|
Scientific title:
|
An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness (Changes of the Aortal Elasticity Due to a Newly Established Aminobiphosphinate Therapy for the Treatment of Osteoporosis) |
|
Date of first enrolment:
|
April 2006 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
http://clinicaltrials.gov/show/NCT00180232 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Joachim Siegert, MDDPharm,Phd |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Technische Universität Dresden |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients starting an aminobisphosphonate therapy due to medical reasons Broca-index:
between -20 and +25% who are willing and capable to confirm written consent to
enrolment after ample information has been provided
Exclusion Criteria:
- patients with major cardiovascular disease patients participating in another clinical
trial 1month prior to inclusion in this study patients unable or unwilling to give
informed consent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Arteriosclerosis
|
|
Osteoporosis
|
|
Secondary ID(s)
|
|
EK160082004
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|